Disaggregated Revenues - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Disaggregation of Revenue [Line Items]
Non-cash royalty revenue		$ 2.3
Revenue from Contract with Customer Benchmark | Customer Concentration Risk | AmerisourceBergen Drug Corporation | Net product sales
Disaggregation of Revenue [Line Items]
Concentration risk percentage	20.00%	20.00%
Revenue from Contract with Customer Benchmark | Customer Concentration Risk | Cardinal Health | Net product sales
Disaggregation of Revenue [Line Items]
Concentration risk percentage	20.00%	20.00%
Revenue from Contract with Customer Benchmark | Customer Concentration Risk | McKesson | Net product sales
Disaggregation of Revenue [Line Items]
Concentration risk percentage	20.00%	20.00%
Revenue from Contract with Customer Benchmark | Customer Concentration Risk | Three Major Customers | Net product sales
Disaggregation of Revenue [Line Items]
Concentration risk percentage	70.00%	70.00%